Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK
about
Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative studyImpact of deploying multiple point-of-care tests with a 'sample first' approach on a sexual health clinical care pathway. A service evaluation.'The waiting game': are current chlamydia and gonorrhoea near-patient/point-of-care tests acceptable to service users and will they impact on treatment?Analysis of the potential for point-of-care test to enable individualised treatment of infections caused by antimicrobial-resistant and susceptible strains of Neisseria gonorrhoeae: a modelling study.Summary and highlights from the International Union against Sexually Transmitted Infections Congress 2014, Malta.Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits.A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy.Auditing the use and assessing the clinical utility of microscopy as a point-of-care test for Neisseria gonorrhoeae in a Sexual Health clinic.'Test n Treat (TnT)': a cluster-randomised feasibility trial of frequent, rapid-testing and same-day, on-site treatment to reduce rates of chlamydia in high-risk further education college students: statistical analysis plan.'Test n Treat (TnT)'- Rapid testing and same-day, on-site treatment to reduce rates of chlamydia in sexually active further education college students: study protocol for a cluster randomised feasibility trial.Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine clinic attendees
P2860
Q35573127-D23C33AE-A06C-42B1-B3E8-5BD81AABB443Q37835010-D5CDC096-A3CB-4ED0-9171-BDFF1C0EAFFFQ37840197-1AD4FA3A-6F4F-48E4-A02F-1723DBA18CD2Q39190909-C96E50B5-6364-4FE5-AF75-CF81B562C49FQ41525727-40FA10B9-E581-4A9F-A6FC-44C65257F5D3Q44059122-B4A93978-E6B0-47DA-B378-06625DB394D0Q49359551-A2518261-3575-4CDC-BC7E-6B37216BB833Q53793991-57CAA046-9A69-4BAA-B1FB-630E059ACD69Q55260830-FBE8B38F-1026-4F4A-899A-2EC983BF1EBAQ55291001-F32DE3B6-61C5-4D97-81E2-69BFD0686A8DQ58753889-640001E4-C69B-4EC8-9292-C5CDD2976B23
P2860
Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mapping patient pathways and e ...... ary medicine clinics in the UK
@ast
Mapping patient pathways and e ...... ary medicine clinics in the UK
@en
type
label
Mapping patient pathways and e ...... ary medicine clinics in the UK
@ast
Mapping patient pathways and e ...... ary medicine clinics in the UK
@en
prefLabel
Mapping patient pathways and e ...... ary medicine clinics in the UK
@ast
Mapping patient pathways and e ...... ary medicine clinics in the UK
@en
P2093
P2860
P50
P1433
P1476
Mapping patient pathways and e ...... ary medicine clinics in the UK
@en
P2093
Alice Ehrlich
Elisabeth J Adams
John Macleod
Robin K Meray
Vikki Pearce
P2860
P304
P356
10.1136/BMJOPEN-2014-005322
P577
2014-07-23T00:00:00Z